vs

Side-by-side financial comparison of i-80 Gold Corp. (IAUX) and STANDARD BIOTOOLS INC. (LAB). Click either name above to swap in a different company.

i-80 Gold Corp. is the larger business by last-quarter revenue ($21.3M vs $19.6M, roughly 1.1× STANDARD BIOTOOLS INC.). STANDARD BIOTOOLS INC. runs the higher net margin — -177.4% vs -401.9%, a 224.5% gap on every dollar of revenue. STANDARD BIOTOOLS INC. produced more free cash flow last quarter ($-23.1M vs $-39.2M).

i-80 Gold Corp is a mineral exploration and development firm focused on gold and silver asset operations in Nevada, US. It advances high-potential mining projects, using responsible extraction practices to deliver precious metals to global industrial and investment markets.

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

IAUX vs LAB — Head-to-Head

Bigger by revenue
IAUX
IAUX
1.1× larger
IAUX
$21.3M
$19.6M
LAB
Higher net margin
LAB
LAB
224.5% more per $
LAB
-177.4%
-401.9%
IAUX
More free cash flow
LAB
LAB
$16.1M more FCF
LAB
$-23.1M
$-39.2M
IAUX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IAUX
IAUX
LAB
LAB
Revenue
$21.3M
$19.6M
Net Profit
$-85.6M
$-34.7M
Gross Margin
22.0%
48.5%
Operating Margin
-291.6%
-168.5%
Net Margin
-401.9%
-177.4%
Revenue YoY
-11.5%
Net Profit YoY
-28.8%
EPS (diluted)
$-0.10
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IAUX
IAUX
LAB
LAB
Q4 25
$21.3M
Q3 25
$32.0M
$19.6M
Q2 25
$27.8M
$21.8M
Q1 25
$14.0M
$40.8M
Q3 24
$11.5M
$22.1M
Q2 24
$7.2M
$22.5M
Q1 24
$45.5M
Q4 23
$28.2M
Net Profit
IAUX
IAUX
LAB
LAB
Q4 25
$-85.6M
Q3 25
$-41.9M
$-34.7M
Q2 25
$-30.2M
$-33.5M
Q1 25
$-41.2M
$-26.0M
Q3 24
$-43.1M
$-26.9M
Q2 24
$-41.0M
$-45.7M
Q1 24
$-32.2M
Q4 23
$-19.8M
Gross Margin
IAUX
IAUX
LAB
LAB
Q4 25
22.0%
Q3 25
9.7%
48.5%
Q2 25
2.9%
48.8%
Q1 25
20.7%
48.4%
Q3 24
-42.7%
54.9%
Q2 24
-171.4%
46.1%
Q1 24
53.1%
Q4 23
47.6%
Operating Margin
IAUX
IAUX
LAB
LAB
Q4 25
-291.6%
Q3 25
-86.7%
-168.5%
Q2 25
-67.4%
-118.1%
Q1 25
-112.3%
-80.8%
Q3 24
-210.0%
-120.9%
Q2 24
-435.2%
-134.5%
Q1 24
-132.2%
Q4 23
-75.9%
Net Margin
IAUX
IAUX
LAB
LAB
Q4 25
-401.9%
Q3 25
-130.8%
-177.4%
Q2 25
-108.5%
-153.7%
Q1 25
-293.3%
-63.8%
Q3 24
-374.5%
-122.0%
Q2 24
-570.8%
-203.3%
Q1 24
-70.6%
Q4 23
-70.2%
EPS (diluted)
IAUX
IAUX
LAB
LAB
Q4 25
$-0.10
Q3 25
$-0.05
$-0.09
Q2 25
$-0.05
$-0.09
Q1 25
$-0.10
$-0.07
Q3 24
$-0.11
$-0.07
Q2 24
$-0.11
$-0.12
Q1 24
$-0.27
Q4 23
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IAUX
IAUX
LAB
LAB
Cash + ST InvestmentsLiquidity on hand
$63.2M
$129.4M
Total DebtLower is stronger
$174.7M
Stockholders' EquityBook value
$346.8M
$399.7M
Total Assets
$703.4M
$539.6M
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IAUX
IAUX
LAB
LAB
Q4 25
$63.2M
Q3 25
$102.9M
$129.4M
Q2 25
$133.7M
$158.6M
Q1 25
$13.5M
$150.9M
Q3 24
$21.8M
$210.6M
Q2 24
$47.8M
$269.8M
Q1 24
$287.1M
Q4 23
$51.7M
Total Debt
IAUX
IAUX
LAB
LAB
Q4 25
$174.7M
Q3 25
$175.9M
Q2 25
$175.8M
Q1 25
$197.5M
Q3 24
$55.2M
Q2 24
$55.1M
Q1 24
$55.0M
Q4 23
$63.5M
Stockholders' Equity
IAUX
IAUX
LAB
LAB
Q4 25
$346.8M
Q3 25
$423.0M
$399.7M
Q2 25
$463.5M
$424.5M
Q1 25
$318.0M
$454.6M
Q3 24
$346.9M
$489.3M
Q2 24
$377.2M
$510.3M
Q1 24
$577.3M
Q4 23
$-148.1M
Total Assets
IAUX
IAUX
LAB
LAB
Q4 25
$703.4M
Q3 25
$756.2M
$539.6M
Q2 25
$782.9M
$557.0M
Q1 25
$659.0M
$579.6M
Q3 24
$681.5M
Q2 24
$708.7M
Q1 24
$777.7M
Q4 23
$323.1M
Debt / Equity
IAUX
IAUX
LAB
LAB
Q4 25
0.50×
Q3 25
0.42×
Q2 25
0.38×
Q1 25
0.62×
Q3 24
0.11×
Q2 24
0.11×
Q1 24
0.10×
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IAUX
IAUX
LAB
LAB
Operating Cash FlowLast quarter
$-34.3M
$-22.2M
Free Cash FlowOCF − Capex
$-39.2M
$-23.1M
FCF MarginFCF / Revenue
-184.3%
-118.1%
Capex IntensityCapex / Revenue
23.1%
4.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-93.2M
$-111.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IAUX
IAUX
LAB
LAB
Q4 25
$-34.3M
Q3 25
$-15.2M
$-22.2M
Q2 25
$-11.3M
$-20.7M
Q1 25
$-22.7M
$-30.3M
Q3 24
$-23.5M
$-27.9M
Q2 24
$-24.6M
$-39.0M
Q1 24
$-62.5M
Q4 23
$-14.1M
Free Cash Flow
IAUX
IAUX
LAB
LAB
Q4 25
$-39.2M
Q3 25
$-18.5M
$-23.1M
Q2 25
$-12.4M
$-22.6M
Q1 25
$-23.1M
$-35.3M
Q3 24
$-23.8M
$-30.1M
Q2 24
$-25.1M
$-41.0M
Q1 24
$-63.3M
Q4 23
$-14.1M
FCF Margin
IAUX
IAUX
LAB
LAB
Q4 25
-184.3%
Q3 25
-57.8%
-118.1%
Q2 25
-44.7%
-103.6%
Q1 25
-164.1%
-86.6%
Q3 24
-206.7%
-136.4%
Q2 24
-349.1%
-182.2%
Q1 24
-138.9%
Q4 23
-50.2%
Capex Intensity
IAUX
IAUX
LAB
LAB
Q4 25
23.1%
Q3 25
10.2%
4.5%
Q2 25
3.9%
8.7%
Q1 25
2.5%
12.4%
Q3 24
2.5%
10.2%
Q2 24
7.3%
8.6%
Q1 24
1.7%
Q4 23
0.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IAUX
IAUX

Granite Creek Mining Company$20.3M95%
Ruby Hill Mining Company LLC$991.0K5%
Lone Tree Minning Company$3.0K0%

LAB
LAB

Consumables$8.7M45%
Services And Other Revenue$5.8M29%
Instruments$5.1M26%

Related Comparisons